Royalty Pharma Plc's

• RPRX's Stock Performance relative to its Competitors

Xbiotech Inc Share Performance -7.38% This Quarter

Xbiotech Inc Profile Xbiotech Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic antibodies. They seek to address unmet medical needs by leveraging their proprietary True Human antibody technology. More about Xbiotech Inc 's Market Share

Galapagos Nv Share Performance -1.01% This Quarter

Galapagos Nv Profile Galapagos Nv's business model is centered around the development and commercialization of innovative medicines. They leverage their expertise in drug discovery and development to collaborate with partners in the healthcare industry, focusing on the advancement of novel therapies to address unmet medical needs. More about Galapagos Nv's Market Share

Mereo Biopharma Group Plc Share Performance -11.14% This Quarter

Mereo Biopharma Group Plc Profile Mereo Biopharma Group Plc's business model focuses on the development and commercialization of innovative therapeutics for rare diseases. More about Mereo Biopharma Group Plc's Market Share

Medicinova Inc Share Performance +36.03% This Year

Medicinova Inc Profile Medicinova Inc operates under a biopharmaceutical business model, primarily focused on the development and commercialization of innovative therapeutics. They strive to identify promising drug candidates with the potential to address unmet medical needs and advance them through clinical trials. By leveraging their research capabilities, strategic partnerships, and licensing opportunities, Medicinova Inc aims to bring these novel treatments to market and improve patient outcomes. More about Medicinova Inc 's Market Share

Biovie Inc Share Performance +26.92% 30 Days

Biovie Inc Profile Biovie Inc is a biotechnology company that aims to develop advanced therapeutic solutions for various diseases. They have a unique business model that focuses on research and development of innovative drugs, strategic partnerships and collaborations with other organizations, along with potential commercialization of their products to generate revenue. Their goal is to create groundbreaking medical treatments that improve the quality of life for patients. More about Biovie Inc 's Market Share

Sources: Royalty Pharma Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 2:28 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Royalty Pharma Plc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.